Table 1. Comparison of demographic and clinicopathologic characteristics between the 2 groups.

Values are presented as mean ± standard deviation or number (%).

Group A, patients receiving chemotherapy within 3 weeks of surgery; group B, patients receiving chemotherapy after 3 weeks of surgery; ASA, American Society of Anesthesiologists; AJCC, American Joint Committee on Cancer; 5-FU, 5-fluorouracil; IV, intravenous; LV, leucovorin; FOLFOX, 5-fluorouracil, leucovorin, and oxaliplatin.

^a)Pearson chi-square test. ^b)Student t-test